PLEXIFORM NEUROFIBROMAS (PN)

Clinical trials for PLEXIFORM NEUROFIBROMAS (PN) explained in plain language.

Never miss a new study

Get alerted when new PLEXIFORM NEUROFIBROMAS (PN) trials appear

Sign up with your email to follow new studies for PLEXIFORM NEUROFIBROMAS (PN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug trial targets shrinking untreatable nerve tumors

Disease control Ongoing

This study is testing whether the drug selumetinib can shrink or slow the growth of large, inoperable nerve tumors (plexiform neurofibromas) in adults with Neurofibromatosis Type 1 (NF1). Participants take capsules twice daily for as long as they tolerate the drug and their disea…

Matched conditions: PLEXIFORM NEUROFIBROMAS (PN)

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

PLEXIFORM NEUROFIBROMAS (PN)

Get alerted when new PLEXIFORM NEUROFIBROMAS (PN) trials appear

New drug trial targets shrinking untreatable nerve tumors